Summary
For Year 2026-27, Syncom Formulations (India) reports the following shareholding: Total Promoters at 50.57%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.21%, Domestic Institutional Investors at 0%, and Retail at 49.21%. This breakdown provides a quick snapshot of ownership distribution for Syncom Formulations (India) in 2026-27.
Syncom Formulations (India) FAQs
As of 04-2026, the promoter shareholding in Syncom Formulations (India) stands at 50.57% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Syncom Formulations (India) is 0.21% and 0% respectively.
The retail shareholding of the Syncom Formulations (India) is 49.21%.
Changes in shareholding patterns of Syncom Formulations (India) can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Syncom Formulations (India) are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Syncom Formulations (India) Associated Pages
- Syncom Formulations (India) Share Price
- Syncom Formulations (India) Share Price chart
- Syncom Formulations (India) Fundamental Analysis
- Syncom Formulations (India) Technical Analysis
- Syncom Formulations (India) Peer Comparison
- Syncom Formulations (India) Share Price History
- Syncom Formulations (India) Board of Directors
